2023-07-012024-06-302024-06-30false09135167LAURISTON LABORATORIES LIMITED2024-08-2086900iso4217:GBPxbrli:pure091351672023-07-01091351672024-06-30091351672023-07-012024-06-30091351672022-07-01091351672023-06-30091351672022-07-012023-06-3009135167bus:SmallEntities2023-07-012024-06-3009135167bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3009135167bus:AbridgedAccounts2023-07-012024-06-3009135167bus:PrivateLimitedCompanyLtd2023-07-012024-06-3009135167core:WithinOneYear2024-06-3009135167core:AfterOneYear2024-06-3009135167core:WithinOneYear2023-06-3009135167core:AfterOneYear2023-06-3009135167core:ShareCapital2024-06-3009135167core:SharePremium2024-06-3009135167core:RevaluationReserve2024-06-3009135167core:OtherReservesSubtotal2024-06-3009135167core:RetainedEarningsAccumulatedLosses2024-06-3009135167core:ShareCapital2023-06-3009135167core:SharePremium2023-06-3009135167core:RevaluationReserve2023-06-3009135167core:OtherReservesSubtotal2023-06-3009135167core:RetainedEarningsAccumulatedLosses2023-06-3009135167core:LandBuildings2024-06-3009135167core:PlantMachinery2024-06-3009135167core:Vehicles2024-06-3009135167core:FurnitureFittings2024-06-3009135167core:OfficeEquipment2024-06-3009135167core:NetGoodwill2024-06-3009135167core:IntangibleAssetsOtherThanGoodwill2024-06-3009135167core:ListedExchangeTraded2024-06-3009135167core:UnlistedNon-exchangeTraded2024-06-3009135167core:LandBuildings2023-06-3009135167core:PlantMachinery2023-06-3009135167core:Vehicles2023-06-3009135167core:FurnitureFittings2023-06-3009135167core:OfficeEquipment2023-06-3009135167core:NetGoodwill2023-06-3009135167core:IntangibleAssetsOtherThanGoodwill2023-06-3009135167core:ListedExchangeTraded2023-06-3009135167core:UnlistedNon-exchangeTraded2023-06-3009135167core:LandBuildings2023-07-012024-06-3009135167core:PlantMachinery2023-07-012024-06-3009135167core:Vehicles2023-07-012024-06-3009135167core:FurnitureFittings2023-07-012024-06-3009135167core:OfficeEquipment2023-07-012024-06-3009135167core:NetGoodwill2023-07-012024-06-3009135167core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3009135167core:ListedExchangeTraded2023-07-012024-06-3009135167core:UnlistedNon-exchangeTraded2023-07-012024-06-3009135167core:MoreThanFiveYears2023-07-012024-06-3009135167core:Non-currentFinancialInstruments2024-06-3009135167core:Non-currentFinancialInstruments2023-06-3009135167dpl:CostSales2023-07-012024-06-3009135167dpl:DistributionCosts2023-07-012024-06-3009135167core:LandBuildings2023-07-012024-06-3009135167core:PlantMachinery2023-07-012024-06-3009135167core:Vehicles2023-07-012024-06-3009135167core:FurnitureFittings2023-07-012024-06-3009135167core:OfficeEquipment2023-07-012024-06-3009135167dpl:AdministrativeExpenses2023-07-012024-06-3009135167core:NetGoodwill2023-07-012024-06-3009135167core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3009135167dpl:GroupUndertakings2023-07-012024-06-3009135167dpl:ParticipatingInterests2023-07-012024-06-3009135167dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3009135167core:ListedExchangeTraded2023-07-012024-06-3009135167dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3009135167core:UnlistedNon-exchangeTraded2023-07-012024-06-3009135167dpl:CostSales2022-07-012023-06-3009135167dpl:DistributionCosts2022-07-012023-06-3009135167core:LandBuildings2022-07-012023-06-3009135167core:PlantMachinery2022-07-012023-06-3009135167core:Vehicles2022-07-012023-06-3009135167core:FurnitureFittings2022-07-012023-06-3009135167core:OfficeEquipment2022-07-012023-06-3009135167dpl:AdministrativeExpenses2022-07-012023-06-3009135167core:NetGoodwill2022-07-012023-06-3009135167core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3009135167dpl:GroupUndertakings2022-07-012023-06-3009135167dpl:ParticipatingInterests2022-07-012023-06-3009135167dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3009135167core:ListedExchangeTraded2022-07-012023-06-3009135167dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3009135167core:UnlistedNon-exchangeTraded2022-07-012023-06-3009135167core:NetGoodwill2024-06-3009135167core:IntangibleAssetsOtherThanGoodwill2024-06-3009135167core:LandBuildings2024-06-3009135167core:PlantMachinery2024-06-3009135167core:Vehicles2024-06-3009135167core:FurnitureFittings2024-06-3009135167core:OfficeEquipment2024-06-3009135167core:AfterOneYear2024-06-3009135167core:WithinOneYear2024-06-3009135167core:ListedExchangeTraded2024-06-3009135167core:UnlistedNon-exchangeTraded2024-06-3009135167core:ShareCapital2024-06-3009135167core:SharePremium2024-06-3009135167core:RevaluationReserve2024-06-3009135167core:OtherReservesSubtotal2024-06-3009135167core:RetainedEarningsAccumulatedLosses2024-06-3009135167core:NetGoodwill2023-06-3009135167core:IntangibleAssetsOtherThanGoodwill2023-06-3009135167core:LandBuildings2023-06-3009135167core:PlantMachinery2023-06-3009135167core:Vehicles2023-06-3009135167core:FurnitureFittings2023-06-3009135167core:OfficeEquipment2023-06-3009135167core:AfterOneYear2023-06-3009135167core:WithinOneYear2023-06-3009135167core:ListedExchangeTraded2023-06-3009135167core:UnlistedNon-exchangeTraded2023-06-3009135167core:ShareCapital2023-06-3009135167core:SharePremium2023-06-3009135167core:RevaluationReserve2023-06-3009135167core:OtherReservesSubtotal2023-06-3009135167core:RetainedEarningsAccumulatedLosses2023-06-3009135167core:NetGoodwill2022-07-0109135167core:IntangibleAssetsOtherThanGoodwill2022-07-0109135167core:LandBuildings2022-07-0109135167core:PlantMachinery2022-07-0109135167core:Vehicles2022-07-0109135167core:FurnitureFittings2022-07-0109135167core:OfficeEquipment2022-07-0109135167core:AfterOneYear2022-07-0109135167core:WithinOneYear2022-07-0109135167core:ListedExchangeTraded2022-07-0109135167core:UnlistedNon-exchangeTraded2022-07-0109135167core:ShareCapital2022-07-0109135167core:SharePremium2022-07-0109135167core:RevaluationReserve2022-07-0109135167core:OtherReservesSubtotal2022-07-0109135167core:RetainedEarningsAccumulatedLosses2022-07-0109135167core:AfterOneYear2023-07-012024-06-3009135167core:WithinOneYear2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3009135167core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3009135167core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3009135167core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3009135167core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3009135167core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3009135167core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3009135167core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3009135167core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3009135167core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3009135167core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3009135167core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3009135167bus:Director12023-07-012024-06-3009135167bus:Director22023-07-012024-06-30091351671bus:Director12023-07-01091351671bus:Director12023-07-012024-06-30091351671bus:Director12024-06-30091351672bus:Director22023-07-01091351672bus:Director22023-07-012024-06-30091351672bus:Director22024-06-30091351672023-07-01091351672023-07-012024-06-30091351672024-06-30

LAURISTON LABORATORIES LIMITED

Registered Number
09135167
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

LAURISTON LABORATORIES LIMITED
Company Information
for the year from 1 July 2023 to 30 June 2024

Directors

AMET, Lorene Eve Aurelie, Dr
STRACHAN, James Melville Donaldson

Registered Address

3rd Floor 207 Regent Street
London
W1B 3HH

Registered Number

09135167 (England and Wales)
LAURISTON LABORATORIES LIMITED
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets328,47013,199
28,47013,199
Current assets
Debtors2,127659
Cash at bank and on hand6,6513,524
8,7784,183
Creditors amounts falling due within one year(30,080)(5,248)
Net current assets (liabilities)(21,302)(1,065)
Total assets less current liabilities7,16812,134
Net assets7,16812,134
Capital and reserves
Called up share capital1010
Profit and loss account7,15812,124
Shareholders' funds7,16812,134
The financial statements were approved and authorised for issue by the Board of Directors on 20 August 2024, and are signed on its behalf by:
AMET, Lorene Eve Aurelie, Dr
Director
Registered Company No. 09135167
LAURISTON LABORATORIES LIMITED
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Vehicles25-
Office Equipment-30
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 July 2334,179
Additions35,172
Disposals(21,245)
At 30 June 2448,106
Depreciation and impairment
At 01 July 2320,980
Charge for year10,938
On disposals(12,282)
At 30 June 2419,636
Net book value
At 30 June 2428,470
At 30 June 2313,199
4.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
AMET, Lorene Eve Aurelie, Dr50112,2502112,730
STRACHAN, James Melville Donaldson55211,831012,383
1,05324,0812125,113